MedTrace Logo

Efficacy and Safety of Surgical Treatment for Type IVa CBD

NCT07036848 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2025-07-17

No results posted yet for this study

Summary

This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for IVa biliary dilatation (BD). Based on this cohort, the study seeks to compare the perioperative risks, long-term outcomes, and quality of life of type IVa BD following surgical treatment, to establish standardized surgical treatment strategies for type IVa BD.

Conditions

  • Choledochal Cyst

Sponsors & Collaborators

  • Beijing Tsinghua Chang Gung Hospital

    lead OTHER

Principal Investigators

  • Shuo Jin, PhD · Beijing Tsinghua Changgeng Hospital

Eligibility

Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-14
Primary Completion
2025-07-14
Completion
2035-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07036848 on ClinicalTrials.gov